Step 1 — Confirm the 510(k) Pathway Applies to Your Device

Not every medical device requires a 510(k). Before investing in submission preparation, determine your device's FDA classification and confirm it is not exempt. A 510(k) is a premarket submission made to the FDA to demonstrate that a device is substantially equivalent to a legally marketed predicate device. Class II devices with moderate risk are the most common candidates for this pathway.

To verify classification, use the FDA product code database or submit a 513(g) request to get the FDA to confirm the classification of your product. If your device is high-risk or has no predicate, you may need the PMA or De Novo pathway instead.

Step 2 — Select and Document Your Predicate Device

Predicate selection is arguably the highest-leverage decision in the entire 510(k) process. A strong predicate shares the same intended use and similar technological characteristics as your device. A poor predicate choice can lead to delays or outright rejection.

Practical Tips for Predicate Research

• Search the FDA 510(k) database for cleared devices with matching product codes and indications for use.
• Review previous submissions for your intended predicate by examining 510(k) summaries posted by FDA and FDA reviewer notes.
• Whenever possible, obtain samples of potential predicate devices for side-by-side testing with your product to generate direct comparison data.
• If your device has significant technological differences, consider including reference devices in your submission alongside the primary predicate to strengthen your equivalence argument.

Step 3 — Execute Design Controls with Manufacturing in Mind

Design controls under 21 CFR 820.30 (now harmonized via QMSR with ISO 13485:2016) require documented design inputs, outputs, reviews, verification, and validation. Critically, these design outputs become the foundation of both your 510(k) submission content and the documentation package your manufacturing team needs.

A common and costly mistake is assuming the product development team has manufacturing in mind as they design the device. The solution is to involve manufacturing engineers or production team leaders early in the design process—not when you are nearing the finish line. They provide insight on manufacturing approaches, component sourcing, and the viability of proposed materials, preventing expensive redesigns later.

Step 4 — Plan and Execute Performance Testing

Comprehensive performance testing is essential for demonstrating substantial equivalence. Depending on your device type, this may include:

• Bench testing against predicate performance specifications
• Electrical safety and electromagnetic compatibility (EMC) testing for active devices
• Software verification and validation with cybersecurity controls (IEC 62304)
• Biocompatibility evaluation per ISO 10993 for patient-contact materials
• Sterilization validation if the device is supplied sterile
• Risk management documentation per ISO 14971 with mitigations linked to design controls

When presenting test data in your submission, include clear summaries explaining why the results are relevant to safety and effectiveness. Use tables, flowcharts, and illustrations to make complex information easily digestible for FDA reviewers.

Step 5 — Align Your Documentation to QMSR Terminology

If you are preparing a 510(k) submission now, you are doing so under the Quality Management System Regulation (QMSR), which went into effect February 2, 2026. The QMSR harmonized FDA's previous Quality System Regulation with ISO 13485:2016. While the underlying documentation requirements are substantially the same, the terminology has changed:

• The Design History File (DHF) is now referred to as the Design and Development File.
• The Device Master Record (DMR) maps to the Medical Device File.
• The Device History Record (DHR) is now referred to as your batch records.

If you are organizing internal documentation under QMSR, use the updated terms to avoid confusion during FDA review. The concepts have not changed, but consistency in language signals regulatory maturity.

Step 6 — Assemble the 510(k) Submission Package

A typical 510(k) submission is very detailed, usually containing about 20 sections running to over 100 pages. The first two sections are FDA forms:

1. Section 1.0 — Medical Device User Fee Cover Sheet (Form FDA 3601): This is essentially a receipt of payment that captures the type of submission and basic applicant information.
2. Section 2.0 — CDRH Premarket Review Submission Cover Sheet (Form FDA 3514): A five-page form covering the type of submission, reason for submission, and applicant details.

Subsequent sections include your device description, indications for use statement, substantial equivalence comparison, performance data summaries, biocompatibility evidence, labeling, sterilization information, and software documentation as applicable. Always verify you are using the current revision of each FDA form before submission.

Step 7 — Consider a Pre-Submission (Pre-Sub) Meeting

The pre-submission process offers an invaluable—and surprisingly underutilized—opportunity to receive FDA feedback before committing to your full submission strategy. Early interaction with FDA reviewers can help identify potential issues before they become roadblocks, align expectations, and potentially streamline the formal review process later. A Pre-Sub is especially worthwhile when:

• Your predicate comparison is non-obvious or involves technological differences
• You are uncertain whether clinical data is required
• Your device uses novel materials or software-driven functionality

Step 8 — Plan the Design Transfer to Manufacturing

Design transfer is the process of providing guidelines to transition a medical device design from the design and development stage into manufacturing. It is not a single handoff event. When done correctly, design transfer occurs throughout the entire design process, with manufacturing considerations baked in from the earliest phases.

Key Activities in Design Transfer

• Demonstrating successful design verification and validation
• Ensuring the Device Master Record (Medical Device File under QMSR) is complete and accurate
• Completing a design transfer checklist covering bill of materials, assembly drawings, finished product specifications, and work instructions
• Confirming that production capability can meet product requirements per ISO 13485

Per ISO 13485, the organization must document procedures to ensure that design and development outputs are verified as suitable for manufacturing before becoming final production specifications. A common pitfall is not having a well-defined design transfer procedure until the transfer phase itself—develop it early, concurrent with product development.

Step 9 — Validate Manufacturing Processes and Run Pilot Production

Process validation is one of the most critical steps in the transfer process. It involves comprehensive validation of all processes, equipment, and software used in manufacturing to ensure they meet specifications and comply with regulatory requirements. This includes developing a validation plan, executing it, and documenting results.

Before scaling to full production, run a pilot production phase to verify efficiency, quality, and consistency. This critical step lets you identify and address potential issues, fine-tune workflows, and confirm that the final product meets all regulatory and performance standards. Areas to verify during pilot runs include:

• Tool performance under actual manufacturing conditions
• Consistent product quality and functionality
• Adherence to delivery timelines
• Yield rates and scrap analysis

Once pilot production is validated, transition to full-scale manufacturing with minimized downtime and a steady supply.

Step 10 — Complete Post-Clearance Activities and Establish Monitoring

After FDA issues a substantial equivalence determination (clearance), several tasks remain before you can begin marketing:

• Device listing: Your device must be listed with the FDA before you begin marketing. Companies sometimes overlook this step, but compliance matters for inspections and customer trust.
• Labeling compliance: Class II devices cleared through the 510(k) pathway are not "FDA approved" devices—that language should never appear in your labeling or marketing materials. Use "FDA cleared" instead.
• Post-market monitoring: Establish a robust system for monitoring the product post-transfer, including a product return and change control process. Process output results should be monitored continuously to identify and resolve anomalies.

Key Takeaways

1. Start manufacturing planning during design, not after. Involving manufacturing engineers early prevents costly redesigns at the moment you want to scale.
2. Predicate selection is strategic. A well-chosen predicate simplifies testing, strengthens your equivalence argument, and accelerates review.
3. Use the Pre-Sub process. FDA feedback before your formal submission can save months of back-and-forth.
4. Align to QMSR terminology now. The regulation took effect in February 2026—use updated terms in all documentation.
5. Process validation is non-negotiable. Pilot production reveals issues that paper reviews cannot catch.
6. Clearance is a milestone, not the finish line. Post-market monitoring and change control keep your device on the market long-term.

How A65 Consulting Supports Your 510(k) and Manufacturing Transfer

A65 Consulting is a premium medical device engineering partner that works from concept to design and delivery. The firm provides engineering leadership and expert support to help teams navigate complex product development with clarity and confidence—including mechanical design, systems engineering, electrical design, and manufacturing support focused on process development, DFM reviews, and smooth production transitions.

Whether you need to close a gap in engineering capability, scale up a design project, or prepare for manufacturing transfer, A65 integrates seamlessly with your team to keep your project on time, on budget, and aligned with product requirements. Book a consultation to discuss your specific device program.

Frequently Asked Questions

What is the difference between FDA clearance and FDA approval?

Class II devices cleared through the 510(k) pathway receive FDA clearance, not approval. The term "FDA approved" applies to high-risk Class III devices that go through the PMA process. Using "FDA approved" for a 510(k)-cleared device is a labeling violation.

How long does the 510(k) review process take?

The FDA targets a 90-day review period from the date it accepts a submission for substantive review. However, additional information requests can extend the timeline significantly. A complete, well-organized submission is the best tool for staying on schedule.

When should I start thinking about design transfer?

At the very beginning of the design process. If you never take manufacturing into account during design, you can easily face expensive delays and design changes at the exact moment you want to scale production.

Do I need a Pre-Sub meeting before filing my 510(k)?

A Pre-Sub is not mandatory, but it is highly recommended when your predicate selection is complex, your device incorporates novel technology, or you are unsure about testing requirements. FDA feedback at this stage can prevent major issues later.

What triggers a new 510(k) if I change my manufacturing site?

A manufacturing site change alone may not require a new 510(k), but it triggers a formal change control process in your QMS that may require regulatory notification or submission. The transfer may have implications for the regulatory status of the product, so plan for this in advance. OEMs retain regulatory responsibility during and after the transfer.

What is included in a design transfer checklist?

A good design transfer checklist includes all documents that need to be passed on to the manufacturing team—bill of materials, assembly drawings, finished product specifications, work instructions, process validation protocols, and verification and validation records.